A mixed methods protocol for an impact and implementation evaluation of the Pharmacy First Services for management of common conditions in England

The evaluation should have service level, policy, professional, and research impact both in England and beyond. This includes generating evidence to show: whether PF contributes to improving primary healthcare access, assessing the quality of antimicrobial use, identifying the scope for refinements to PF, and, overall, informing better implementation of PF. The findings will also provide robust evidence to enable policymakers to determine how to enhance the role of community pharmacy in England in the future. Furthermore, the evaluation will develop a data dashboard, and the methods and codes used to interrogate it (though not the patient data), will be made publicly available that could support other similar evaluations in England and internationally.

Authors

Institutions

Publication Details

Journal
International Journal of Pharmacy Practice
Published
2025-03-05
DOI
https://doi.org/10.1093/ijpp/riaf004
Citations
6
Primary Topic
Primary Care and Health Outcomes
Type
article
Field-Weighted Citation Impact
16.89
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A mixed methods protocol for an impact and implementation evaluation of the Pharmacy First Services for management of common conditions in England

Mirza Lalani, Berit Müller‐Pebody, Anthony Avery, Nicholas Mays et al.
6 citations
International Journal of Pharmacy Practice
Primary Care and Health Outcomes
16.89
article

A mixed methods protocol for an impact and implementation evaluation of the Pharmacy First Services for management of common conditions in England

Mirza Lalani, Berit Müller‐Pebody, Anthony Avery, Nicholas Mays, James Goulding, Kimberley Sonnex, Rachel Elliott, R. E. Glover, Diane Ashiru‐Oredope, Amelia Taylor, Agata Pacho, Brian MacKenna, Hannah Higgins, Claire Anderson, Stephen O’Neill, Tracey Thornley, Thomas Allen, Carol Coupland, Stacy M. Johnson
article en
6 citations

Abstract

The evaluation should have service level, policy, professional, and research impact both in England and beyond. This includes generating evidence to show: whether PF contributes to improving primary healthcare access, assessing the quality of antimicrobial use, identifying the scope for refinements to PF, and, overall, informing better implementation of PF. The findings will also provide robust evidence to enable policymakers to determine how to enhance the role of community pharmacy in England in the future. Furthermore, the evaluation will develop a data dashboard, and the methods and codes used to interrogate it (though not the patient data), will be made publicly available that could support other similar evaluations in England and internationally.

International Journal of Pharmacy PracticeVol. 33(2)
National Security Agency (US), University of Nottingham (GB), Manchester Academic Health Science Centre (GB), John Radcliffe Hospital (GB), University of Manchester (GB), University of Oxford (GB), Park University (US), London School of Hygiene & Tropical Medicine (GB), Queen's Medical Centre (GB)
Openalex Percentile: Top 1%
Primary Care and Health Outcomes
16.89
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.